Strattera, also known as atomoxetine, is a non-stimulant medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). It was first approved by the FDA in 2002 and has been a significant revenue generator for Eli Lilly.
Atomoxetine, a non-stimulant medication, is approved for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD). It helps improve impulsive disorders and treats anxiety disorders.
Strattera is available under the brand names TAD and NPactive for prescriptions and generics. It is also approved to help treat symptoms of anxiety in adults in their 60s and 70s. Emphasize abstinence from alcohol and avoid smoking while taking Strattera.
Strattera operates on the basis of its function as a gamma-Aminobutyric-Gacist. This is a neurotransmitter that is involved in regulating alertness, motivation, and the excitability of certain functions in the brain.
In a context where positive symptoms are common, gamma-Aminobutyric-Gacist medications like atomoxetine help maintain calm and reduce anxiety.
For those who require an alternative treatment option, the use of Kaletra may represent a game-changer. Using Kaletra instead of Strattera, which is characterized by an absence of stimulant effects in standard ADHD treatment, provides the same results.
With the aid of the medication, individuals can reach a euphoric high, reduced fatigue, and improved social interactions. This makes it a preferred choice among clinicians due to its non-stimulant nature.
The use of atomoxetine, a medication frequently prescribed to treat ADHD, has faced significant research. Researchers have identified several potential side effects of atomoxetine, including sleep disturbances, drowsiness, and fatigue. Furthermore, it has been associated with increased risk of certain cancers, including breast and uterine cancer.
Strattera, a non-stimulant medication, is available in several forms, including tablets, capsules, and powder for injection formulations. The ideal form for patients requires a comprehensive understanding of its uses and potential side effects.
Kaletra, a non-stimulant medication commonly prescribed for ADHD, presents challenges in terms of dosage and administration regimens. The mechanism through which Kaletra alters brain neurotransmitters, such as gamma-aminobutyric acid (GABA), may lead to side effects like drowsiness, dizziness, and weight gain. Additionally, it has been associated with increased risk of certain cancers, including breast and uterine cancer.
With the aid of atomoxetine, individuals can reach a significant increase in energy levels and improved social interactions when using it.
Monitoring of attention span, restlessness, and sedation is essential for assessing the effectiveness of using atomoxetine. This includes regular appointments with healthcare providers to monitor for any signs of increased drowsiness, sedation, or dizziness. Ensure that you closely follow your healthcare provider's instructions regarding dosage and administration.
Regular monitoring of blood pressure is advisable to ensure the safe use of atomoxetine. This includes monitoring for any signs of fainting or heart palpitations. Maintaining open communication with your healthcare provider while taking atomoxetine may help prevent any adverse effects related to this medication.
Strattera, also known as atomoxetine, is a medication commonly prescribed to treat Attention Deficit Hyperactivity Disorder (ADHD). It's primarily known for its ability to improve impulsive behavior and reduce anxiety. Its mechanism of action involves improving GABA levels in the brain, leading to a decrease in impulsivity and hyperactivity.
Medically reviewed by Jessica Swirble, PharmDLast updated on April 18, 2025
Drug Information| | |
Atomoxetine is a medication classified as a selective norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of the neurotransmitters norepinephrine and dopamine, which helps improve mood and emotions.
Atomoxetine is prescribed to treat attention-deficit hyperactivity disorder (ADHD), a condition that causes excessive levels of norepinephrine and dopamine in the brain.
The drug is also used for purposes not listed in the medication guide.
Atomoxetine is typically taken once a day, typically once a day. It is important to follow your healthcare provider's instructions and not exceed the prescribed dosage to see an effective dose increase.
Follow the prescribed dosage and instructions closely to ensure the best possible effect.
Generic versions are available to manage different medications, but they are FDA-approved and controlled substances. If you have any questions about your medication, healthcare, or want to discuss your treatment, contact your healthcare provider or visit a pharmacy.
Last Updated: April 18, 2025
The on-demand version of The Med website contains the fastest and most reliable way to get medication and order online. On-demand online pharmacies sell prescription medications, as well as prescription supplies, at a significantly lower price. Medication is a fast-acting, convenient, and costeffective option for obtaining healthcare products and healthcare supplies online. On-demand services include telemedicine, online virtual consultations, and other on-demand services. Medication is available 24/7, with a range of products, including on-demand supplies, at a variety of convenient prices.
- Pharmacy support available at any time - Access to medications can be difficult to obtain - Access to products may be limited - Access to on-demand products are available - For medication questions or concerns, contact The Med website:
|
Common Brand-Name and Generic Name:atomoxetine
Dosage Formtablet
The dosage of Strattera is based on your age, medical history, and response to treatment. It is important to follow your healthcare provider's instructions and not exceed the recommended dosage. Dosing adjustments may be needed if required. Atomoxetine is available as a generic medication. Strattera is a prescription medication and should only be taken under the supervision of a healthcare provider.
Available Dosages---proclaimed Strattera | |On-Demand
The medication comes in different strengths, including 10mg, 20mg, and 40mg. The recommended starting dose is 10mg, taken once a day. Atomoxetine comes in different dosages, which depend on your response to the medication and the potential side effects.
Strattera is a prescription medication and should only be taken as prescribed by your doctor. Dosing adjustments may be needed based on the response to the medication. Generic versions of The Med website are available to manage different medications, but they are FDA-approved and controlled substances.
The medication is available in various strengths, including 10mg, 20mg, and 40mg.
Atomoxetine (Strattera) is a medication that has gained popularity as a treatment for attention-deficit hyperactivity disorder (ADHD). This medication works by increasing the levels of norepinephrine in the brain, which helps improve attention and reduce impulsivity. Atomoxetine is approved for treating adult ADHD, as are some other medications approved for this condition. Here’s a comparison of Atomoxetine vs. Strattera, as well as some key points about each treatment option: 1. Treatment for ADHD: Atomoxetine is a medication that has gained popularity as a treatment for ADHD, which is a condition in which attention and impulse control are impaired. Atomoxetine belongs to a class of medications called selective norepinephrine reuptake inhibitors (SNRIs). By increasing norepinephrine levels, Strattera helps improve attention and reduce impulsivity, and atomoxetine can help with ADHD symptoms.
In this article, we will compare Atomoxetine vs. Strattera, as well as the specific medication you may be prescribed. We will also look at how each treatment option works for your specific condition and how each medication compares.
Atomoxetine, also known by its generic name atomoxetine, is a medication that has gained popularity in the treatment of ADHD. It belongs to a class of drugs called tricyclic antidepressants (TCAs), which are used to treat ADHD. They work by increasing the levels of serotonin in the brain, which helps to improve attention and reduce impulsivity. Atomoxetine is approved for ADHD in adults, and can be prescribed for children and adolescents. However, it is important to note that Atomoxetine can also be prescribed for individuals with ADHD who do not respond well to stimulants, such as methylphenidate (Ritalin), or amphetamine (Adderall).
While Strattera and Atomoxetine are effective medications for treating ADHD, they have several potential side effects. Strattera is known for its relatively mild side effects, and some medical professionals may not be aware of them. Strattera may cause gastrointestinal issues such as nausea, headache, and diarrhea, while Atomoxetine may cause sleep disturbances such as difficulty falling asleep and staying asleep. It’s important to be aware of the possible side effects of Strattera and to seek medical attention if they are severe or persistent.
The standard dosages of Atomoxetine and Strattera for ADHD are as follows:Adults and Children 12 to 17 Years:Atomoxetine is available in the following strengths: 20 mg, 40 mg, and 80 mg. The dosage for children and adolescents is typically higher than that for adults. Strattera, on the other hand, is available in the 20 mg, 40 mg, and 80 mg dosage strengths, and the dosage for adults is typically higher than the dosage for children. Children and adolescents should take atomoxetine at least one hour before or two hours after taking stimulants. It is important to take atomoxetine exactly as directed on the label, and to complete the full course of treatment as prescribed by your healthcare provider. If you miss a dose, skip the missed dose and take the next dose at the regular scheduled time. If you have taken atomoxetine and are on the next dose, you should not take the missed dose. If you have taken atomoxetine and have missed a dose of Strattera, skip the missed dose and take the next dose at the regular scheduled time. Do not take a double dose of atomoxetine to make up for a missed dose.
When taking atomoxetine and Strattera, there are a few key points to keep in mind:
Strattera (atomoxetine) is a non-stimulant drug approved by the U. S. Food and Drug Administration (FDA) for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and Attention-Deficit/Hyperactivity Disorder-Secondary Hyperactivity Disorder (ADHD-SAD). It is taken once daily in doses of 60mg three times a day, which is divided into three doses: 60mg once daily, 60mg three times a day.
Strattera has been studied in the treatment of ADHD-SAD, an inpatient psychiatric program and outpatient drug treatment program for a variety of conditions. It is taken once-daily, as needed, for the treatment of ADHD-SAD. Strattera has been used in the treatment of both primary and secondary ADHD.
The Food and Drug Administration has not approved atomoxetine for the treatment of ADHD-SAD. The drug is not approved for the treatment of ADHD-SAD in adults. As of 2019, atomoxetine is approved for the treatment of ADHD-SAD, which is the second most common ADHD in the United States. Atomoxetine is a selective norepinephrine reuptake inhibitor and the first approved drug in the class of medications for ADHD, which include stimulant medications. Strattera has been evaluated for the treatment of ADHD-SAD by a clinical evaluation program for more than 2 years. This program is also supported by the U. Food and Drug Administration (FDA) for the treatment of primary ADHD. As of 2019, the FDA has not approved atomoxetine for the treatment of ADHD-SAD. For the treatment of ADHD-SAD, Strattera has been evaluated by an inpatient psychiatric program. The program also is supported by the U. Food and Drug Administration (FDA) for the treatment of ADHD-SAD, which is the second most common ADHD in the United States.
The approved indication for the treatment of ADHD-SAD in adults is defined by the American College of Gastroenterology. The American Society of Gastrointestinal Medicine is an independent third-party medical organization and represents the manufacturer of atomoxetine.
FDA approval for the treatment of ADHD-SAD requires the approval of the following:
Stade de France Pharmacy